Resverlogix Corp. (TSX:RVX)
Canada · Delayed Price · Currency is CAD 0.1100
-0.0050 (-4.35%)
At close: Feb 27, 2026
Resverlogix Market Cap
Resverlogix has a market cap or net worth of CAD 34.73 million as of March 2, 2026. Its market cap has increased by 146.71% in one year.
Market Cap
34.73M
Enterprise Value
155.00M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since April 25, 2003, Resverlogix's market cap has increased from 22.94M to 34.73M, an increase of 51.39%. That is a compound annual growth rate of 1.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 34.73M | 20.77% |
| Dec 31, 2025 | 28.76M | 85.71% |
| Dec 31, 2024 | 15.48M | -18.72% |
| Dec 29, 2023 | 19.05M | -48.74% |
| Dec 30, 2022 | 37.17M | -70.01% |
| Dec 31, 2021 | 123.91M | -43.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 62.62M |
| MedMira | 48.82M |
| Sernova Biotherapeutics | 47.47M |
| Devonian Health Group | 38.03M |
| BriaCell Therapeutics | 37.78M |
| Defence Therapeutics | 35.00M |
| Microbix Biosystems | 33.25M |
| Telescope Innovations | 28.69M |